Karus Therapeutics Announces Strategic Collaboration with The University of Texas MD Anderson Cancer Center
Oxford, UK, 10 December 2015 – Karus Therapeutics (‘Karus’), a leader in the development of innovative medicines with breakthrough potential in the treatment of hematological cancers and solid tumor immunotherapy, today announced that it has entered into a strategic pre-clinical and clinical collaboration with The University of Texas MD Anderson Cancer Center. The collaboration will […]